poorly differentiated neuroendocrine carcinoma

Neuroendocrine carcinoma of unknown primary site
Poorly differentiated neuroendocrine carcinoma. REFERENCES . Poorly differentiated neuroendocrine carcinoma of unknown primary site: a newly . ->
poorly differentiated neuroendocrine carcinoma

Poorly Differentiated Carcinoma of the Mediastinum
Poorly Differentiated Carcinoma of the Mediastinum -Etiology, Epidemiology, Histopathology, Clinical Characteristics, . differentiated neuroendocrine . ->
poorly differentiated neuroendocrine carcinoma

IAP 2006 Slide Seminar #03 - Pancreas Pathology - Case 5
Poorly differentiated neuroendocrine carcinoma of the pancreas producing somatostatin. . Patients with poorly differentiated neuroendocrine carcinomas usually fare . ->
poorly differentiated neuroendocrine carcinoma

L1 is a potential marker for poorly-differentiated pancreatic .
L1 is a potential marker for poorly-differentiated pancreatic. neuroendocrine carcinoma . 1b) or poorly-differentiated neuroendocrine carcinoma . ->
poorly differentiated neuroendocrine carcinoma

World J Gastroenterol
. a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma . with poorly-differentiated neuroendocrine carcinoma according to . ->
poorly differentiated neuroendocrine carcinoma

Neuroendocrine Tumours of the Lung
Small Cell Carcinoma - poorly differentiated and - Large Cell Neuroendocrine Carcinoma - poorly differentiated. . differentiated neuroendocrine carcinoma . ->
poorly differentiated neuroendocrine carcinoma

Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma .
Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma associated . lymph node were consistent with poorly differentiated neuroendocrine carcinoma. . ->
poorly differentiated neuroendocrine carcinoma

Moderately Differentiated Neuroendocrine Carcinoma of the Larynx
Well differentiated neuroendocrine carcinoma (typical carcinoid) is an extremely . Poorly differentiated or small cell neuroendocrine carcinoma is similar in . ->
poorly differentiated neuroendocrine carcinoma

High Grade (Poorly Differentiated) Neuroendocrine Carcinoma
. for North American NeuroEndocrine Tumor Society, neuroendocrine tumor (NET) disease . High Grade (Poorly Differentiated) Neuroendocrine Carcinoma . ->
poorly differentiated neuroendocrine carcinoma

Phase II Trial of Paclitaxel, Carboplatin, and Etoposide in Advanced .
. Advanced Poorly Differentiated Neuroendocrine Carcinoma: A Minnie . poorly differentiated neuroendocrine carcinoma and had received no previous treatment. . ->
0 comment(s)
Add a comment
Emots
emotemotemotemotemot
emotemotemotemotemot
emotemotemotemotemot
emotemotemotemotemot
emotemotemotemotemot
Enable HTML
Enable UBB
Enable Emots
Hidden
Remember
Nickname   Password   Optional
Site URI   Email   [Register]
               

 
All Right Reserved Email:20425238 (at) QQ.com If the copyright of any content belongs to you, contact us and we'll remove it!